Hooray.
This has been a long trial and it's good to get the final patient in there.
So with the recent update to clinicaltrials saying that the concussion trial should finish in June 2016 we can hop for the following trial results:
By end 2015: FXS trial
1st half 2016: TBI trial
2nd half 2016: concussion trial.
By end of June next year the next Rett trial should be well underway and, if the FXS trial is successful, I would hope we'd have some guidance on the next phase for FXS.
Ann: Neuren completes enrolment in INTREPID clinical trial, page-3
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.30 |
Change
-0.200(1.03%) |
Mkt cap ! $2.466B | |||
| Open | High | Low | Value | Volume |
| $19.50 | $19.59 | $19.11 | $5.729M | 296.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 259 | $19.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.31 | 640 | 2 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |